Advanced Glycation End Products in Renal Failure

Journal of Renal Nutrition

Volumn 16, Issue 3, 2006, Pages 178-184

  Thornalley, Paul J ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; GLYCOSYLATION; HUMAN; KIDNEY FAILURE; METABOLISM; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; UREMIA;

CARDIOVASCULAR DISEASES; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PROTEINS; RENAL DIALYSIS; RISK FACTORS; UREMIA;

EID: 33745659414     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.04.012     Document Type: Article

References (32)

1. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899
2. Thornalley P.J., Battah S., Ahmed N., et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375 (2003) 581-592
3. Thornalley P.J. Clinical significance of glycation. Clin Lab 45 (1999) 263-273
4. Thornalley P.J. Dicarbonyl intermediates in the Maillard reaction. Ann N Y Acad Sci 1043 (2005) 111-117
5. Thornalley P.J. The enzymatic defence against glycation in health, disease and therapeutics. A symposium to examine the concept. Biochem Soc Trans 31 (2003) 1343-1348
6. Thornalley P.J. Glyoxalase I-Structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 31 (2003) 1343-1348
7. Niwa T. 3-Deoxyglucosone. Metabolism, analysis, biological activity, and clinical implication. J Chromatogr B 731 (1999) 23-36
8. Szwergold B.S., Howell S., and Beisswenger P.J. Human fructosamine-3-kinase. Purification, sequencing, substrate specificity, and evidence of activity in vivo. Diabetes 50 (2001) 2139-2147
9. Ahmed N., Thornalley P.J., Dawczynski J., et al. Methylglyoxal-derived hydroimidazolone advanced glycation endproducts of human lens proteins. Invest Ophthalmol Vis Sci 44 (2003) 5287-5292
10. Haik Jr. G.M., Lo T.W.C., and Thornalley P.J. Methylglyoxal concentration and glyoxalase activities in human lens. Exp Eye Res 59 (2004) 497-500
11. Agalou S., Ahmed N., Babaei-Jadidi R., et al. Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol 16 (2005) 1471-1485
12. Friedlander M.A., Wu Y.W., Elgawish A., et al. Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97 (1996) 728-735
13. Nakamura S., Miyazaki S., Sakai S., et al. Localization of imidazolone in the peritoneum of CAPD patients. A factor for a loss of ultrafiltration. Am J Kidney Dis 38 (2001) S107-S110
14. Honda K., Nitta K., Horita S., et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14 (1999) 1541-1549
15. Owen W.F., Lew N.L., Liu Y., et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329 (1993) 1001-1006
16. Mortier S., Faict D., Schalkwijk C.G., et al. Long-term exposure to new peritoneal dialysis solutions. Effects on the peritoneal membrane. Kidney Int 66 (2004) 1257-1265
17. Penelope Catalan M., Santamaria B., Reyero A., et al. 3,4-Di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 68 (2005) 1303-1311
18. Justo P., Sanz A.B., Egido J., et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 54 (2005) 2424-2429
19. Welten A.G.A., Schalkwijk C.G., ter Wee P.M., et al. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation endproducts (AGEs) and a proinflammatory response. Perit Dial Int 23 (2003) 213-221
20. Witowski J., Korybalska K., Wisniewska J., et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 11 (2000) 729-739
21. Amore A., Cappelli G., Cirina P., et al. Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant 18 (2003) 677-688
22. 1. Amelioration by trypsin. Kidney Int 59 (2001) 53-57
23. Morgan L.W., Wieslander A., Davies M., et al. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 64 (2003) 1854-1866
24. Inagi R., Miyata T., Yamamoto T., et al. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells. Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 463 (1999) 260-264
25. Lee H.Y., Park H.C., Seo B.J., et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance). Perit Dial Int 25 (2005) 248-255
26. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 44 (1998) 1013-1023
27. Thornalley P.J. Glycation, receptor-mediated cell activation and vascular complications of diabetes. Diabetes Vasc Dis Res 1 (2004) 21-22
28. Ahmed N., Dobler D., Dean M., et al. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 280 (2005) 5724-5732
29. Dobler D., Ahmed N., and Thornalley P.J. Peptide mapping of type IV collagen modified minimally by methylglyoxal in vitro. Ann N Y Acad Sci 1043 (2004) 906
30. Pedchenko V.K., Chetyrkin S.V., Chuang P., et al. Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes 54 (2005) 2952-2960
31. Paul R.G., and Bailey A.J. The effect of advanced glycation end-product formation upon cell-matrix interactions. Int J Biochem Cell Biol 31 (2004) 653-660
32. Segal M.S., Bihorac A., and Koc M. Circulating endothelial cells. Tea leaves for renal disease. Am J Physiol Renal Physiol 283 (2002) F11-F19